Edward Hall Nominated to Join the Board of Directors of TPI Composites, Inc.
SCOTTSDALE, Ariz., April 09, 2024 (GLOBE NEWSWIRE) — TPI Composites, Inc. (TPI) (Nasdaq: TPIC) announced today that Edward “Ned” Hall […]
Leslie’s Appoints Benjamin Lindquist Senior Vice President, General Counsel & Corporate Secretary
PHOENIX, April 09, 2024 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s”, “we”, “our”, “its”, or “Company”; NASDAQ: LESL), the largest and […]
AvidXchange Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) — AvidXchange Holdings, Inc. (Nasdaq: AVDX), a leading provider of accounts payable (AP) […]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
LPL Financial Announces First Quarter 2024 Earnings Release Date and Conference Call
SAN DIEGO, April 09, 2024 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of […]
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision […]
Rapid7 to Report First Quarter 2024 Financial Results on May 7
BOSTON, April 09, 2024 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today […]
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
IRVINE, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company […]
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
VANCOUVER, British Columbia, April 09, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina” or the “Company”), a biopharmaceutical […]
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
CARMEL, Ind., April 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology […]
